Introduction

Artificial Intelligence is an attempt to simulate human intelligence. Digital breast-to-motor synthesis, or DBT for short, has become widely accepted for breast cancer screening. The first commercially available mammographic AI-based tool was approved by the FDA in 1998. It was aimed at detecting suspicious findings to increase radiologists' sensitivity for cancer detection. But as time passed and the technology world evolved, the use of AI in medicine also evolved.